Description
About Retatrutide
Retatrutide is a triple-action peptide that targets the GIP, GLP-1, and glucagon pathways. Its potential benefits include appetite control, weight-management support, healthy glucose metabolism, and overall metabolic support.
Potential Benefits
- Appetite control
- Weight-management support
- Healthy glucose metabolism
- Metabolic support
Available Options
Available in 10 mg, 20 mg, and 30 mg.
Quality
Batch-specific testing documentation is available where shown on the product page or by request.
Retatrutide is investigational and is not approved by the FDA for therapeutic use.
Research Use Only: For laboratory research use only. Not for human or veterinary use.
